Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis

Clicks: 396
ID: 268003
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #70 of 183 articles by views in The New England journal of medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A 7-day course of doxycycline was superior to single-dose azithromycin in the treatment of rectal chlamydia infection among men who have sex with men. (Funded by the National Health and Medical Research Council; RTS Australian New Zealand Clinical Trials Registry number, ACTRN12614001125617.).
Reference Key
a2021theazithromycin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lau A;Kong FYS;Fairley CK;Templeton DJ;Amin J;Phillips S;Law M;Chen MY;Bradshaw CS;Donovan B;McNulty A;Boyd MA;Timms P;Chow EPF;Regan DG;Khaw C;Lewis DA;Kaldor J;Ratnayake M;Carvalho N;Hocking JS;;
Journal The New England journal of medicine
Year 2021
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.